Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease

Published:2014-10-10 Issue:12 Volume:16 Page:
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Yu Mark Shipeng,Folt David A.,Drummond Christopher A.,Haller Steven T.,Cooper Emily L.,Brewster Pamela,Evans Kaleigh L.,Cooper Christopher J.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11883-014-0459-4.pdf

Reference81 articles.

1. Cooper CJ et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22. This is the primary report from the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL), a prospective randomized clinical trial. This trial compared patients receiving optimal medical therapy alone versus optimal medical therapy with stenting and concluded that stenting therapy does not provide more benefit than medical therapy alone.

2. Evans KL et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol. 2014;9(7):1199–206. This article reported the current ACEI/ARB usage in patients with atherosclerotic renal artery stenosis from the CORAL trial. Although ACEI/ARB usage has been shown to be beneficial in reducing mortality and morbidity in patients with ARVD, clinicians do not always prescribe ACEI/ARBs to these patients.

3. Hansen KJ et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443–51.

4. Kalra PA et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37–43.

5. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009;27(7):1333–40.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Artery Interventions;Interventional Cardiology;2022-05-06

2. Design of a clinical risk calculator for major clinical outcomes in patients with atherosclerotic renovascular disease;Nephrology Dialysis Transplantation;2018-06-22

3. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease;Kidney International;2018-04

4. Quantitative evaluation of atherosclerotic plaques and intraplaque neovascularization using contrast-enhanced ultrasound after treatment with atorvastatin in rabbits;Biomedicine & Pharmacotherapy;2017-08

5. Renal Artery Interventions;Interventional Cardiology;2016-11-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3